Psoriasis pill showdown: which works better?
NCT ID NCT07261306
Summary
This study compares two existing oral medications—methotrexate and tofacitinib—to see which is more effective at reducing psoriasis symptoms. It involves 75 adults with moderate-to-severe plaque psoriasis that hasn't responded well to creams and ointments. Researchers will measure how much each medication reduces skin redness, thickness, and scaling over 12 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lahore general hospital
RECRUITINGLahore, Punjab Province, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.